Analysts are estimating that Edwards Lifesciences will report an earnings per share (EPS) of $0.62.
The announcement from Edwards Lifesciences is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Performance in Previous Earnings
During the last quarter, the company reported an EPS beat by $0.08, leading to a 1.23% drop in the share price on the subsequent day.
Here's a look at Edwards Lifesciences's past performance and the resulting price change:
Quarter
Q3 2025
Q2 2025
Q1 2025
Q4 2024
EPS Estimate
0.59
0.62
0.60
0.55
EPS Actual
0.67
0.67
0.64
0.59
Price Change %
-1.00
6.00
7.00
7.00
Stock Performance
Shares of Edwards Lifesciences were trading at $78.71 as of February 06. Over the last 52-week period, shares are up 9.6%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analyst Insights on Edwards Lifesciences
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Edwards Lifesciences.
Analysts have given Edwards Lifesciences a total of 20 ratings, with the consensus rating being Buy. The average one-year price target is ...
